Miyahira AK, Sharp A, Ellis L, Jones J, Kaochar S, Larman HB, et al. Prostate cancer research: the next generation; report from the 2019 Coffey-Holden prostate cancer academy meeting. Prostate. 2020;80(2):113–32.
Gonzalez LO, Eiro N, Fraile M, Beridze N, Escaf AR, Escaf S, et al. Prostate cancer tumor stroma: responsibility in tumor biology, diagnosis and treatment. Cancers. 2022;14(18):4412.
Article CAS PubMed PubMed Central Google Scholar
Van Poppel H, Roobol MJ, Chapple CR, Catto JW, N’Dow J, Sønksen J, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021. Eur Urol. 2021;80(6):703–11.
Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht HA, et al. Survival rate of prostate cancer in Asian countries: a systematic review and meta-analysis. Ann Glob Health. 2020;86(1):2.
Article PubMed PubMed Central Google Scholar
Baskaran S, Selvam MKP, Agarwal A. Exosomes of male reproduction. Adv Clin Chem. 2020;95:149–63.
Article CAS PubMed Google Scholar
Kandalan RN, Nguyen D, Rezaeian NH, Barragán-Montero AM, Breedveld S, Namuduri K, et al. Dose prediction with deep learning for prostate cancer radiation therapy: model adaptation to different treatment planning practices. Radiother Oncol. 2020;153:228–35.
Article CAS PubMed PubMed Central Google Scholar
Habib A, Jaffar G, Khalid MS, Hussain Z, Zainab SW, Ashraf Z, et al. Risk factors associated with prostate cancer. J Drug Deliv Ther. 2021;11(2):188–93.
Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.
Article CAS PubMed PubMed Central Google Scholar
Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, Golubnitschaja O. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11(3):399–418.
Article PubMed PubMed Central Google Scholar
Berenguer CV, Pereira F, Câmara JS, Pereira JA. Underlying features of prostate cancer—statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30(2):2300–21.
Article PubMed PubMed Central Google Scholar
Williams IS, McVey A, Perera S, O’Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217(8):424–33.
Article PubMed PubMed Central Google Scholar
Yan Y, Yeon SY, Qian C, You S, Yang W. On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances. Int J Mol Sci. 2021;22(24):13537.
Article CAS PubMed PubMed Central Google Scholar
Kouspou MM, Fong JE, Brew N, Hsiao ST, Davidson SL, Choyke PL, et al. The movember prostate cancer landscape analysis: an assessment of unmet research needs. Nat Rev Urol. 2020;17(9):499–512.
Article PubMed PubMed Central Google Scholar
Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet. 2011;129(6):687–94.
Article CAS PubMed PubMed Central Google Scholar
Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, et al. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis. 2011;32(6):853–9.
Article CAS PubMed PubMed Central Google Scholar
Zafar I, Anwar S, Yousaf W, Nisa FU, Kausar T, ul Ain Q, et al. Reviewing methods of deep learning for intelligent healthcare systems in genomics and biomedicine. Biomed Signal Process Control. 2023;86:105263.
Ahmad HM, Abrar M, Izhar O, Zafar I, Rather MA, Alanazi AM, et al. Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: pharmacophore, virtual screening, and MD simulation techniques. J King Saud Univ Sci. 2022;34(6):102186.
Ali S, Ali U, Qamar A, Zafar I, Yaqoob M, Ain QU, et al. Predicting the effects of rare genetic variants on oncogenic signaling pathways: a computational analysis of HRAS protein function. Front Chem. 2023;11:1173624.
Article CAS PubMed PubMed Central Google Scholar
Turnham DJ, Bullock N, Dass MS, Staffurth JN, Pearson HB. The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells. 2020;9(11):2342.
Article CAS PubMed PubMed Central Google Scholar
Milella M, Falcone I, Conciatori F, Incani UC, Del Curatolo A, Inzerilli N, et al. PTEN: multiple functions in human malignant tumors. Front Oncol. 2015;5:24.
Article PubMed PubMed Central Google Scholar
Shiota M (2021) Oxidative stress and prostate cancer. In: Cancer, pp 15–26. Academic Press.
Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk RK, Milner TA, et al. NKX3.1 localization to mitochondria suppresses prostate cancer initiation. Cancer Discov. 2021;11(9):2316–33.
Article CAS PubMed PubMed Central Google Scholar
Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol. 2018;15(4):222–34.
Article CAS PubMed PubMed Central Google Scholar
Gülhan Ö, Mahi B. The role of AMACR, CD10, TMPRSS2-ERG, and p27 protein expression among different Gleason grades of prostatic adenocarcinoma on needle biopsy. Clin Med Insights Oncol. 2020;14:1179554920947322.
Article PubMed PubMed Central Google Scholar
Mkabile S, Swartz L. Caregivers’ and parents’ explanatory models of intellectual disability in Khayelitsha, Cape Town, South Africa. J Appl Res Intellect Disabil. 2020;33(5):1026–37.
Kumar BK, Faheem N, Sekhar KVGC, Ojha R, Prajapati VK, Pai A, Murugesan S. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J Biomol Struct Dyn. 2022;40(3):1363–86.
Article CAS PubMed Google Scholar
Zafar I, Safder A, Imran Afridi H, Riaz S, -ur-Rehman R, Unar A, et al. In silico and in vitro study of bioactive compounds of Nigella sativa for targeting neuropilins in breast cancer. Front Chem. 2023;11:11273149.
Mouada H, Lanez T, Zafar I. ROS scavenging, DNA binding and NADPH oxidase inhibition potential of N’-Ferrocenylmethyl-N’-phenylpropionohydrazide using cyclic voltammetry and molecular docking. J Organomet Chem. 2024;1007:123026.
Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 2020;126(1):46–57.
Fujita K, Nonomura N. Role of androgen receptor in prostate cancer: a review. World J Mens Health. 2019;37(3):288–95.
White J. PubMed 2.0. Med Ref Serv Q. 2020;39(4):382–7.
Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell. 2023;6:1169595.
Comments (0)